All Stories

  1. Metabolically healthy and unhealthy obesity in erectile dysfunction and male infertility
  2. An update on heart disease risk associated with testosterone boosting medications
  3. Neuropsychiatric Aspects in Men with Klinefelter Syndrome
  4. Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS
  5. Hyponatremia, falls and bone fractures: A systematic review and meta-analysis
  6. Sex hormone-binding globulin is associated with androgen deficiency features independently of total testosterone
  7. Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis
  8. Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data
  9. Tumor Necrosis Factor α Impairs Kisspeptin Signaling in Human Gonadotropin-Releasing Hormone Primary Neurons
  10. Sexuality in eating disorders patients: etiological factors, sexual dysfunction and identity issues. A systematic review
  11. THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study
  12. The pharmacotherapy of male hypogonadism besides androgens
  13. Hypogonadism as an additional indication for bariatric surgery in male morbid obesity?
  14. Tadalafil Effect on Metabolic Syndrome‐Associated Bladder Alterations: An Experimental Study in a Rabbit Model
  15. Clinical correlates of enlarged prostate size in subjects with sexual dysfunction
  16. fertilità maschile
  17. Dehydroepiandrosterone Supplementation in Elderly Men: A Meta-Analysis Study of Placebo-Controlled Trials
  18. FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS
  19. The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction
  20. Impaired Masturbation‐Induced Erections: A New Cardiovascular Risk Factor for Male Subjects with Sexual Dysfunction
  21. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis
  22. Two Unconventional Risk Factors for Major Adverse Cardiovascular Events in Subjects with Sexual Dysfunction: Low Education and Reported Partner's Hypoactive Sexual Desire in Comparison with Conventional Risk Factors
  23. Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements
  24. Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells
  25. Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells
  26. Human Bladder as a Novel Target for Vitamin D Receptor Ligands
  27. Androgens Regulate Phosphodiesterase Type 5 Expression and Functional Activity in Corpora Cavernosa
  28. Oxytocin Receptor Is Expressed in the Penis and Mediates an Estrogen-Dependent Smooth Muscle Contractility
  29. Inhibition of Spontaneous and Androgen-Induced Prostate Growth by a Nonhypercalcemic Calcitriol Analog
  30. Estrogens, But Not Androgens, Regulate Expression and Functional Activity of Oxytocin Receptor in Rabbit Epididymis